Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Amgen |
---|---|
Information provided by: | Amgen |
ClinicalTrials.gov Identifier: | NCT00446446 |
This is an open-label, single-arm, phase 2, multi-center, clinical trial of panitumumab monotherapy for second-line treatment of metastatic or recurrent squamous cell carcinoma of head and neck (SCCHN) subjects. This study will be conducted in North America. Approximately 50 subjects with histologically or cytologically confirmed metastatic and/or recurrent SCCHN will be enrolled into the trial.
Condition | Intervention | Phase |
---|---|---|
Cancer Carcinoma Head and Neck Cancer Metastases Metastatic Cancer Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck Oncology Squamous Cell Carcinoma Tumors |
Drug: Panitumumab |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Phase 2, Single-Arm, Open-Label, Multi-Center Trial of Second-Line Panitumumab Monotherapy in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck |
Estimated Enrollment: | 50 |
Study Start Date: | May 2007 |
Estimated Study Completion Date: | May 2011 |
Estimated Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
panitumumab: Experimental
Single Arm Monotherapy Study
|
Drug: Panitumumab
Single Arm Monotherapy Study
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Amgen Call Center | 866-572-6436 |
Study Director: | MD | Amgen |
Responsible Party: | Amgen Inc. ( Global Development Leader ) |
Study ID Numbers: | 20062088 |
Study First Received: | March 8, 2007 |
Last Updated: | November 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00446446 |
Health Authority: | United States: Food and Drug Administration; United States: Institutional Review Board |
Epidermoid carcinoma Squamous cell carcinoma Head and Neck Neoplasms Carcinoma, squamous cell Neoplasm Metastasis Neoplasms, Squamous Cell |
Carcinoma, Squamous Cell Carcinoma, squamous cell of head and neck Recurrence Neoplasms, Glandular and Epithelial Carcinoma |
Neoplastic Processes Neoplasms Pathologic Processes Neoplasms by Site Neoplasms by Histologic Type |